Dr. Neel Trivedi, MD

Dr. Trivedi practices at Nazareth Hospital in Philadelphia, Pennsylvania, part of Trinity Health.

Dr. Trivedi's NPI, 1467870113, was assigned on March 31, 2014. Dr. Trivedi holds New Jersey license 25MA12464000.

Dr. Trivedi's primary practice is Nazareth Hospital, at 2601 Holme Ave, Philadelphia, PA 19152 in Philadelphia County. The practice phone is (215) 335-6000.

Dr. Trivedi's primary practice is Nazareth Hospital in Philadelphia, Pennsylvania, part of Trinity Health. Dr. Trivedi is also affiliated with Cooper University Hospital. The medical group on file is Clinical Care Associates (CCA), Penn Medicine. Dmand AI also links Dr. Trivedi to 4 more hospitals, 2 skilled nursing facilities, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Trivedi practices, 9 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Trivedi's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Trivedi's licenses on file in 2 states: New Jersey and Pennsylvania.

CMS data shows 338 Medicare services from Dr. Trivedi across 10 procedure codes in 2024, for 181 Medicare patients. Medicare paid $28,549 for them.

CMS counts 181 Medicare patients who saw Dr. Trivedi in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 43% are also on Medicaid. Their average risk score is 2.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Trivedi's median patient age at 64, with 56% women.

In 2024, Dr. Trivedi wrote 225 Medicare Part D claims for 56 patients. 55% of them were for generic drugs. CMS names the drug for 99 of them, across 3 drugs with 11 or more claims each, at $59,596 in total drug cost. In 2023, CMS named 111 claims across 7 drugs.

Dr. Trivedi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Trivedi as offering telehealth.

Dmand AI links 3 papers to Dr. Trivedi in 2021. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Trivedi's most frequent co-authors are Bruce David Cheson, MD, John Frederick Deeken, MD and Nadia Khan, MD.

CMS Open Payments shows 93 general payments to Dr. Trivedi from 34 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 67% of the total. Genentech, Inc. paid the most, $6,998.